BPBibianna Purgina

Bibianna Purgina

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Bibianna Purgina has a total of 23 co-authors. Here are the top co-authors by number of shared publications:

  • A. N. Flaman

    Division of Anatomical Pathology, Department of Pathology and Laboratory Medicine, The Ottawa Hospital/University of Ottawa, Ottawa, Canada

    2 shared publications
  • D. H. Gravel

    Division of Anatomical Pathology, Department of Pathology and Laboratory Medicine, The Ottawa Hospital/University of Ottawa, Ottawa, Canada

    2 shared publications
  • J. K. Wasserman

    Division of Anatomical Pathology, Department of Pathology and Laboratory Medicine, The Ottawa Hospital/University of Ottawa, Ottawa, Canada

    2 shared publications
  • Anita Nagy

    Division of Pathology, The Hospital for Sick Children, Toronto, ON, Canada

    1 shared publication
  • Carl Ren

    Department of Pathology and Laboratory Medicine University of British Columbia Vancouver British Columbia Canada

    1 shared publication
  • Chi K. Lai

    Division of Anatomical Pathology, Department of Pathology and Laboratory Medicine, The Ottawa Hospital, University of Ottawa, 501 Smyth Road, 4th Floor CCW, Room 4114, Ottawa, Ontario K1H 8L6, Canada

    1 shared publication

Latest Publications

  • Open Access

    CDKN2A deletion in p16‐negative/ HPV ‐positive head and neck squamous cell carcinoma: Highlighting the molecular basis behind the limitation of relying on p16 immunohistochemistry as a surrogate marker for HPV involvement

    by Trevor Teich, Rong Hu, Anita Nagy, Mary Shago, Yen Chen Kevin Ko, Carl Ren, Raja R Seethala, Bibianna Purgina, Elan Hahn

    Aims: Immunohistochemistry (IHC) for p16 is widely used as a surrogate marker for HPV involvement in oropharyngeal squamous cell carcinoma (OPSCC), among other tumours. Confirming HPV status in OPSCC is critical, as HPV‐positive tumours have better overall survival and may require de‐escalated therapy compared to HPV‐independent OPSCC in the future. However, discordance exists between p16 and HPV, and direct HPV testing is occasionally required to ensure an accurate diagnosis. The aim of this study is to highlight the genomic basis behind the limitation of relying on p16 IHC as a surrogate marker for HPV involvement. Methods and Results: Through a multi‐institutional collaboration, this case series compiled four patients with a ‘false’ negative p16 staining pattern in HPV‐positive non‐keratinizing head and neck squamous cell carcinoma. All cases demonstrated minimal to no p16 IHC staining and were positive for HPV by direct RNA in situ hybridization. Through CDKN2A fluorescence in situ hybridization testing, three patients demonstrated a homozygous deletion of CDKN2A and one demonstrated a heterozygous deletion. Conclusions: This series highlights the genomic basis for the ‘false’ negative p16 results, raising awareness of a significant diagnostic pitfall while emphasizing the importance of careful consideration of clinicopathologic parameters in the clinical workup of these cases.


  • Open Access

    TFEB -Amplified Renal Cell Carcinoma: Integrating Histopathologic and Molecular Diagnostics with Therapeutic Implications

    by Julia Esber, Bibianna M. Purgina, Kevin Hogan, Nicola Schieda, Finn M. Auld, Ilias Cagiannos, Trevor A. Flood

    TFEB -amplified renal cell carcinoma (RCC) represents a newly described and rare aggressive molecular subtype of RCC that is characterized by TFEB gene amplification (6p21.1). These tumors are characterized by heterogeneous morphology (papillary, tubulocystic, and nested patterns), eosinophilic/clear cytoplasm, and prominent nucleoli with perinucleolar clearing. We present a diagnostically challenging lesion in a 72-year-old man who was found to have a 9.8 cm partially necrotic renal mass during work up for decreased renal function and hematuria. The nephrectomy specimen revealed a large tumor invading into the renal vein, renal sinus, and perinephric fat. Histology showed a heterogeneous tumor of clear or eosinophilic cells with prominent nucleoli and occasional perinucleolar clearing. Apically oriented nuclei were noted surrounding tubulocystic structures, as were several multinucleated tumor cells. Immunohistochemistry demonstrated Pan-keratin/Mel-A positivity. Notably, PAX8 was negative in the majority of the tumor and PD-L1 had a CPS of TFEB amplification (6-15 copies) and confirmed the diagnosis of TFEB -amplified RCC. Despite combined immunotherapy and anti-angiogenic therapy, the patient succumbed to rapid metastatic progression 5 months postoperatively, underscoring the tumor's aggressive behavior and current therapeutic limitations. This report outlines the diagnostic complexities associated with TFEB -amplified RCC and emphasizes the need for effective management strategies.


  • Mammary-type myofibroblastoma of the thigh mimicking liposarcoma

    by Natasha Akhlaq, Bibianna Purgina, Joel Werier, Zaid Jibri

    Myofibroblastoma is a rare tumor that was originally described in the breast but has since been found in extra-mammary locations, where it been renamed mammary-type myofibroblastoma (MTM). We describe a case of MTM occurring in the anterior compartment of the thigh, which was initially interpreted as a possible a liposarcoma on MRI. Two subsequent biopsy samples and eventual excision revealed the tumor to have the characteristic pathology of MTM. This benign tumor, albeit rare, needs to be considered in the imaging differential diagnosis of fat containing deep soft tissue masses of the extremity.


  • Soft Tissue Special Issue: Chondroid Neoplasms of the Skull

    by A. N. Flaman, J. K. Wasserman, D. H. Gravel, B. M. Purgina

    Clinically, radiologically, and pathologically, chondroid neoplasms of the skull can be diagnostically challenging due to overlapping features in each of these domains. Compounding the problem for the pathologist, there is also significant morphologic, immunophenotypic, and molecular genetic overlap between benign and malignant cartilaginous lesions, and the majority of these lesions are encountered quite rarely in routine surgical pathology practice. Each of these factors contribute to the diagnostic difficulty posed by these lesions, highlighting the importance of radiologic-pathologic correlation in the diagnosis. This review is intended to provide an update for surgical pathologists on some of the most commonly encountered chondroid neoplasms in the skull, and includes the following lesions: chondromyxoid fibroma, synovial chondromatosis, chondrosarcoma and variants, and chordoma and variants. For each of these lesions, the differential diagnosis and useful ancillary tests will be discussed in the context of a broad range of additional primary and secondary lesions.


  • Ear and Temporal Bone Pathology: Neural, Sclerosing and Myofibroblastic Lesions

    by A. N. Flaman, J. K. Wasserman, D. H. Gravel, B. M. Purgina

    Neural, sclerosing, and myofibroblastic lesions of the ear and temporal bone present diagnostic challenges for both clinicians and pathologists due to significant overlap in their clinical presentations, histologic appearances, and immunohistochemical profiles. While some of these lesions, such as schwannomas, are relatively common, others are rendered even more difficult because they are encountered very rarely in routine surgical pathology practice. This review is intended to provide an update on the pathology of some of the most commonly encountered primary diagnostic entities for the ear and temporal bone, and includes the following neural lesions: schwannoma, meningioma, and encephalocele/meningocele. Sclerosing lesions that will be discussed include spindle cell and sclerosing rhabdomyosarcoma, sclerosing epithelioid fibrosarcoma, and sclerosing paraganglioma. Finally, myofibroblastic lesions that will be reviewed are nodular fasciitis, IgG4-related disease, and solitary fibrous tumor. For each of these lesions, the differential diagnosis and useful ancillary tests will be discussed in the context of a broad range of additional primary and secondary lesions.


  • Chordoma of the Head and Neck: A Review

    by Jason K. Wasserman, Denis Gravel, Bibianna Purgina

    Chordoma is a rare malignant bone tumor that can arise anywhere along the central neural axis and many involve head and neck sites, most commonly the skull base. The relative rarity of these tumors, combined with the complex anatomy of the head and neck, pose diagnostic challenges to pathologists. This article describes the pertinent clinical, pathologic, and molecular features of chordomas and describes how these features can be used to aid in formulating a differential diagnosis. Emphasis is placed on key diagnostic pitfalls and the importance of incorporating immunohistochemical information into the diagnosis.